MTX-474

· Mediar Therapeutics

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for MTX-474, covering 2025-05-18 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: EncompaSSc: Evaluation of MTX-474 in Participants With Diffuse Cutaneous Systemic Sclerosis (dcSSc) [Phase 2]